Novartis Mergers & Acquisitions

Novartis M&A Summary

Novartis has acquired 40 companies, including 15 in the last 5 years. A total of 9 acquisitions came from private equity firms. It has also divested 8 assets.

Novartis’ largest acquisition to date was in 2025, when it acquired Avidity Biosciences for $12.0B. It’s largest disclosed sale occurred in 2014, when it sold Novartis Animal Health to Eli Lilly and Co. for $5.4B. Novartis has acquired in 11 different US states, and 6 countries. The Company’s most targeted sectors include life science (84%) and medical products (9%).

M&A Summary

  • M&A Total Activity44
    • M&A Buy Activity36
    • M&A Sell Activity8
  • Total Sectors Invested 4
  • Total Countries Invested 6
  • M&A Buy/Sell Connections 21

Novartis

Novartis AG

Lichtstrasse 35,
Basel, 4056
Switzerland,
+41 61 324 11 11
www.novartis.com

All (44) Buy (36) Sell (8)
Date Target Value
$mlns
Transaction Type Acquirer Seller SRC
Link
2025-10-26 Avidity Biosciences · Life Science
San Diego, California · www.aviditybiosciences.com

Avidity Biosciences is a biotechnology company that develops oligonucleotide-based therapies using its proprietary antibody oligonucleotide conjugate platform. Avidity Biosciences was founded in 2012 and is based in San Diego, California.

Revenue (mlns) 11 USD
Advisors: Barclays Investment Bank , Goldman Sachs , Kirkland & Ellis
12,000
1,118.4x REVENUE
Merger

Novartis

-

Try Mergr Free — See This and 220,573+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 214K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 83K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.